Davidoff Cancer Center, Rabin Medical Center

Petah Tikva 4941494

0 studies enrolling now · 2 studies all time

What they study most

Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations

Studies at this site

• To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) — Stopped early
• Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations — Stopped early